Child Abuse Review
© John Wiley & Sons, Ltd.
Edited By: Jane V. Appleton and Peter Sidebotham
Impact Factor: 0.787
ISI Journal Citation Reports © Ranking: 2013: 21/40 (Social Work); 27/39 (Family Studies)
Online ISSN: 1099-0852
NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate, please visit our policy statement
For additional tools visit Author Resources - an enhanced suite of online tools for Wiley InterScience journal authors, featuring Article Tracking, E-mail Publication Alerts and Customized Research Tools.
A guide to writing for publication in Child Abuse Review: click here for a concise, practical guide to writing a paper for publication.
1. Initial Manuscript Submission
Submitted manuscripts should not have been previously published and should not be submitted for publication elsewhere while they are under consideration by Wiley. Submitted material will not be returned to the author unless specifically requested.
Child Abuse Review has now adopted ScholarOne Manuscripts , for online manuscript submission and peer review. The new system brings with it a whole host of benefits including:
- Quick and easy submission
- Administration centralised and reduced
- Significant decrease in peer review times
From now on all submissions to the journal must be submitted online at http://mc.manuscriptcentral.com/car. Full instructions and support are available on the site and a user ID and password can be obtained on the first visit. If you require assistance then click the Get Help Now link which appears at the top right of every ScholarOne Manuscripts page. If you cannot submit online, please contact Diane Heath in the Editorial Office (firstname.lastname@example.org).
2. Manuscript style
The language of the journal is English. All submissions must have a title, be double-line spaced and have a margin of 3cm all round. Illustrations and tables must be supplied separately, and not be incorporated into the text. Their proposed location should be indicated in the text.
The paper must include:
- A title page with the full title, the names and affiliations of all authors and a running headline. Give the full address, including email, telephone and fax, of the author who is to check the proofs.
- The name(s) of any sponsor(s) or research funder(s), along with grant number(s).
- An unstructured abstract of up to 200 words for all Papers. An abstract is a concise summary of the whole Paper, not just the conclusions, and is understandable without reference to the rest of the Paper. It should contain no citation to other published work.
- Up to 75 words as bullet points outlining the Key Practitioner Messages contained in the paper.
- Up to five keywords that describe your Paper, for indexing purposes.
- The word-length of the manuscript at the end.
- The number of references
Papers (excluding tables and references) should be between 3,000 and 5,000 words, Short Reports and Case Studies should be between 1,000 and 2,500 and do not require an abstract. Papers should have no more than 35 references.
3. Reporting and interpretation of Statistical Results
When reporting and interpreting the findings of a statistical analysis the authors should focus on the clinical importance of the results rather than simply the statistical evidence. In order to do this, the confidence interval for any parameter estimate is crucial, although the standard error would also be acceptable. Do the implications of these results differ
depending on where in the confidence interval the true value may lie?
The p-value indicates the statistical evidence (against the null hypothesis). Authors should refrain from the use of the word significant to describe results for which a p-value is less than 0.05, instead considering the level of evidence against the null hypothesis in combination with the clinical importance as described above.
For further reading, see
Sterne JA, Davey Smith G.
Sifting the evidence - what's wrong with significance tests?
BMJ. 2001 Jan 27;322(7280):226-31.
4. Ethical Guidelines
Child Abuse Review adheres to the ethical guidelines for publication and research summarised below.
4.1. Authorship and Acknowledgements
Authorship: Authors submitting a paper do so on the understanding that the manuscript has been read and approved by all authors and that all authors agree to the submission of the manuscript to the Journal. ALL named authors must have made an active contribution to the conception and design and/or analysis and interpretation of the data and/or the drafting of the paper and ALL must have critically reviewed its content and have approved the final version submitted for publication. Participation solely in the acquisition of funding or the collection of data does not justify authorship and, except in the case of complex large-scale or multi-centre research, the number of authors should not exceed six.
Child Abuse Review adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). According to the ICMJE authorship criteria should be based on 1) substantial contributions to conception and design of, or acquisition of data or analysis and interpretation of data, 2) drafting the article or revising it critically for important intellectual content and 3) final approval of the version to be published. Authors should meet conditions 1, 2 and 3.
It is a requirement that all authors have been accredited as appropriate upon submission of the manuscript. Contributors who do not qualify as authors should be mentioned under Acknowledgements.
Acknowledgements: Under Acknowledgements please specify contributors to the article other than the authors accredited. Please also include specifications of the source of funding for the study and any potential conflict of interests if appropriate. Suppliers of materials should be named and their location (town, state/county, country) included.
4.2. Ethical Approvals
Research involving human participants will only be published if such research has been conducted in full accordance with ethical principles, including the World Medical Association Declaration of Helsinki (version, 2002 http://www.wma.net/en/30publications/10policies/b3/index.html) and the additional requirements, if any, of the country where the research has been carried out. Manuscripts must be accompanied by a statement that the research was undertaken with the understanding and written consent of each participant (or the participant’s representative, if they lack capacity), and according to the above mentioned principles. A statement regarding the fact that the study has been independently reviewed and approved by an ethical board should also be included.
All studies using human participants should include an explicit statement in the Material and Methods section identifying the review and ethics committee approval for each study, if applicable. Editors reserve the right to reject papers if there is doubt as to whether appropriate procedures have been used.
Ethics of investigation: Papers not in agreement with the guidelines of the Helsinki Declaration as revised in 1975 will not be accepted for publication.
4.3 Clinical Trials
Clinical trials should be reported using the CONSORT guidelines available at www.consort-statement.org. A CONSORT checklist should also be included in the submission material (http://www.consort-statement.org/mod_product/uploads/CONSORT 2001 checklist.doc).
Child Abuse Review encourages authors submitting manuscripts reporting from a clinical trial to register the trials in any of the following free, public clinical trials registries: www.clinicaltrials.gov,www.isrctn.org. The clinical trial registration number and name of the trial register will then be published with the paper.
4.4 Conflict of Interest and Source of Funding
Conflict of Interest: Authors are required to disclose any possible conflict of interest. These include financial (for example patent, ownership, stock ownership, consultancies, speaker’s fee). Author’s conflict of interest (or information specifying the absence of conflicts of interest) will be published under a separate heading entitled ’Conflict of Interests’.
Child Abuse Review requires that sources of institutional, private and corporate financial support for the work within the manuscript must be fully acknowledged, and any potential conflicts of interest noted. Please include this information under the separate headings of 'Source of Funding' and 'Conflict of Interest' at the end of your manuscript.
If the author does not include a conflict of interest statement in the manuscript then the following statement will be included by default: “No conflicts of interest have been declared”.
Source of Funding: Authors are required to specify the source of funding for their research when submitting a paper. Suppliers of materials should be named and their location (town, state/county, country) included. The information will be disclosed in the published article.
5. Reference style
Harvard style must be used. In the text the names of authors should be cited followed by the date of publication, e.g. Adams & Boston (1993). Where there are three or more authors, the first author's name followed by et al. should be used in the text, e.g. Goldberg et al. (1994). The reference list should be prepared on a separate sheet with names listed in alphabetical order. The references should list authors’ surnames and initials, date of publication, title of article, name of book or journal, volume number or edition, editors, publisher and place of publication. In the case of an article or book chapter, page numbers should be included routinely.
All references must be complete and accurate. Where possible the DOI* for the reference should be included at the end of the reference. Online citations should include date of access. If necessary, cite unpublished or personal work in the text but do not include it in the reference list.
References should be listed in the following style:
Munro E. 2008. Effective Child Protection. Sage Publications: Los Angeles, USA.
Parton N. 2007. Safeguarding children: a socio-historical analysis. In: The child protection handbook (3rd ed.), Wilson K & James A (eds). Bailliere Tindall: Edinburgh; pp. 9-30.
St James-Roberts I. 2007. Helping parents to manage infant crying and sleeping: A review of the evidence and its implications for services. Child Abuse Review 16: 47-69. DOI: 10.1002/car.968
*The Digital Object Identifier (DOI) is an identification system for intellectual property in the digital environment. Developed by the International DOI Foundation on behalf of the publishing industry, its goals are to provide a framework for managing intellectual content, link customers with publishers, facilitate electronic commerce, and enable automated copyright management.
All figures and artwork must be provided in electronic format. Please save vector graphics (e.g. line artwork) in Encapsulated Postscript Format (EPS) and bitmap files (e.g. halftones) or clinical or in vitro pictures in Tagged Image Format (TIFF). Further information can be obtained at Wiley-Blackwell’s guidelines for illustrations: http://authorservices.wiley.com/bauthor/illustration.asp
7. Copyright and Permissions
Copyright Transfer Agreement
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.
For authors signing the copyright transfer agreement
If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:
For authors choosing OnlineOpen
If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Creative Commons Attribution License OAA
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.
If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.
Permission grants - if the manuscript contains extracts, including illustrations, from other copyright works (including material from on-line or intranet sources) it is the author's responsibility to obtain written permission from the owners of the publishing rights to reproduce such extracts using the Wiley Permission Request Form .
Submission of a manuscript will be held to imply that it contains original unpublished work and is not being submitted for publication elsewhere at the same time. Submitted material will not be returned to the author, unless specifically requested.
8. Further Information
Most papers will require some revisions. Proofs will be sent to the author for checking. This stage is to be used only to correct errors that may have been introduced during the production process. Prompt return of the corrected proofs, preferably within two days of receipt, will minimise the risk of the Paper being held over to a later issue. Free access to the final PDF offprint of your article will be available via Author Services only. Please therefore sign up for Author Services if you would like to access your article PDF offprint and enjoy the many other benefits the service offers. Additional copies of the journal may be ordered.
NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate, please visit our policy statement